aller au contenu
Bad medicine : the prescription drug industry in the Third World Aperçu de cet ouvrage
FermerAperçu de cet ouvrage
Vérification...

Bad medicine : the prescription drug industry in the Third World

Auteur : Milton Silverman; Mia Lydecker; Philip R Lee
Éditeur: Stanford, Calif. : Stanford University Press, 1992.
Édition/format:   Livre imprimé : AnglaisVoir toutes les éditions et tous les formats
Résumé:
The pharmaceutical industry has long and vehemently insisted that it has the willingness, the dedication, and the ability to police itself to insure that the public will not be unnecessarily harmed or defrauded. As the record shows with painful clarity, however, virtually no industry or professional group has ever adequately policed itself, and the pharmaceutical industry is no exception. Where the most flagrant  Lire la suite...
Évaluation:

moyenne basée sur 1 évaluation(s) 0 avec des critiques - Soyez le premier.

Sujets
Plus comme ceci

Trouver un exemplaire en ligne

Liens vers cet ouvrage

Trouver un exemplaire dans la bibliothèque

&AllPage.SpinnerRetrieving; Recherche de bibliothèques qui possèdent cet ouvrage...

Détails

Type d’ouvrage: Ressource Internet
Type de document: Livre, Ressource Internet
Tous les auteurs / collaborateurs: Milton Silverman; Mia Lydecker; Philip R Lee
ISBN: 0804716692 9780804716697
Numéro OCLC: 24376708
Description: xvii, 358 pages ; 24 cm
Contenu: The patients : health for all by, when? --
Drug labeling : how safe? how deadly? --
The companies : heroes or villains? --
The great generics controversy --
The dipyrone affair --
The case of the deadly pregnancy test --
Bangladesh and the noble experiment --The drug swindlers --
So shines a good deed --
Ammunition for the consumers --
Consumer power : the Hansson/Ciba-Geigy connection --
The essential role of government --
Hard choices.
Responsabilité: Milton Silverman, Mia Lydecker, Philip R. Lee.
Plus d’informations:

Résumé:

Shows how local drug firms in the Third World have taken advantage of loose regulatory practices and unscrupulous behavior on the part of regional and national health care professionals to promote  Lire la suite...

Critiques

Critiques éditoriales

Synopsis de l’éditeur

'Bad Medicine offers a wealth of information which is urgently needed by health policy planners, health professionals, consumers, and the pharmaceutical industry. To my knowledge, this objective and Lire la suite...

 
Critiques d’utilisateurs
Récupération des critiques de GoodReads...
Récuperation des critiques DOGObooks…

Marqueurs

Soyez le premier.
Confirmez cette demande

Vous avez peut-être déjà demandé cet ouvrage. Veuillez sélectionner OK si vous voulez poursuivre avec cette demande quand même.

Données liées


Primary Entity

<http://www.worldcat.org/oclc/24376708> # Bad medicine : the prescription drug industry in the Third World
    a schema:Book, schema:CreativeWork ;
   library:oclcnum "24376708" ;
   library:placeOfPublication <http://id.loc.gov/vocabulary/countries/cau> ;
   library:placeOfPublication <http://experiment.worldcat.org/entity/work/data/26745098#Place/stanford_calif> ; # Stanford, Calif.
   schema:about <http://dewey.info/class/338.476151091724/e20/> ;
   schema:about <http://experiment.worldcat.org/entity/work/data/26745098#Place/entwicklungslander> ; # Entwicklungsländer.
   schema:about <http://experiment.worldcat.org/entity/work/data/26745098#Topic/arzneimittelversorgung> ; # Arzneimittelversorgung
   schema:about <http://experiment.worldcat.org/entity/work/data/26745098#Topic/developing_countries> ; # Developing Countries
   schema:about <http://experiment.worldcat.org/entity/work/data/26745098#Organization/drug_industry_standards> ; # Drug Industry standards
   schema:about <http://experiment.worldcat.org/entity/work/data/26745098#Topic/wirtschaftsethik> ; # Wirtschaftsethik
   schema:about <http://id.worldcat.org/fast/1060133> ; # Pharmaceutical industry--Corrupt practices
   schema:about <http://experiment.worldcat.org/entity/work/data/26745098#Topic/drug_industry> ; # Drug Industry
   schema:about <http://experiment.worldcat.org/entity/work/data/26745098#Topic/pharmaceutical_policy_developing_countries> ; # Pharmaceutical policy--Developing countries
   schema:about <http://id.worldcat.org/fast/1242969> ; # Developing countries.
   schema:about <http://experiment.worldcat.org/entity/work/data/26745098#Topic/gesundheitspolitik> ; # Gesundheitspolitik
   schema:about <http://experiment.worldcat.org/entity/work/data/26745098#Topic/pharmaceutical_industry_corrupt_practices_developing_countries> ; # Pharmaceutical industry--Corrupt practices--Developing countries
   schema:about <http://experiment.worldcat.org/entity/work/data/26745098#Topic/social_responsibility> ; # Social Responsibility
   schema:about <http://id.worldcat.org/fast/1060194> ; # Pharmaceutical policy
   schema:about <http://experiment.worldcat.org/entity/work/data/26745098#Topic/pharmazeutische_industrie> ; # Pharmazeutische Industrie
   schema:bookFormat bgn:PrintBook ;
   schema:contributor <http://viaf.org/viaf/33296294> ; # Philip Randolph Lee
   schema:contributor <http://viaf.org/viaf/263277518> ; # Mia Lydecker
   schema:creator <http://viaf.org/viaf/45574724> ; # Milton Silverman
   schema:datePublished "1992" ;
   schema:description "The patients : health for all by, when? -- Drug labeling : how safe? how deadly? -- The companies : heroes or villains? -- The great generics controversy -- The dipyrone affair -- The case of the deadly pregnancy test -- Bangladesh and the noble experiment --The drug swindlers -- So shines a good deed -- Ammunition for the consumers -- Consumer power : the Hansson/Ciba-Geigy connection -- The essential role of government -- Hard choices."@en ;
   schema:description "The pharmaceutical industry has long and vehemently insisted that it has the willingness, the dedication, and the ability to police itself to insure that the public will not be unnecessarily harmed or defrauded. As the record shows with painful clarity, however, virtually no industry or professional group has ever adequately policed itself, and the pharmaceutical industry is no exception. Where the most flagrant abuses have been exposed and corrected, major credit must probably be divided among the media that publicized the situation, consumer groups that applied pressure, government officials who took actions that were often unpopular, and individual members of the pharmaceutical industry who had the courage to face up to their social responsibilities. To this number should perhaps be added the three authors of this volume who have, in a series of books such as Pills, Profits, and Politics, The Drugging of America, and Prescriptions for Death: The Drugging of the Third World, exposed fraudulent practices by U.S. and multinational pharmaceutical companies. In this book, the authors turn their attention to what happened in Third World countries when, because of worldwide pressures, the multinational drug companies largely corrected their notorious abuses. On the basis of painstaking research, much of it conducted in a great many Third World countries, the authors conclude that a plethora of small local firms have filled the dishonest sales channels vacated by the multinationals. The authors show in great detail how local drug firms in the Third World have taken advantage of loose regulatory practices and unscrupulous behavior on the part of regional and national health care professionals to promote the sale of dangerous or worthless drugs as remedies for diseases for which they were never intended. Warnings of bad side effects are omitted from promotional literature, drugs are sold that have not had proper trials, and drug firms have often bribed government officials, doctors, and hospital administrators in order to gain favorable treatment in the importation and sale of their products. Among the many topics treated in this book are the controversy over inexpensive generic drugs (including disclosures of fraud and bribery in the U.S. Food and Drug Administration), the actions of consumer groups, and the key role of government in preventing abuses by drug firms. The authors describe a remarkable attempt in Bangladesh, one of the poorest of all the developing countries, to develop a high-quality local drug industry. They also present as case histories reports on three extremely important drug products or groups--the dipyrones (for control of pain and fever), high-dosage estrogen-progesterone hormone products (for use in pregnancy tests), and clioquinol or Enterovioform (for treatment of diarrhea)--all of which were or still are centers of worldwide, heated controversy."@en ;
   schema:exampleOfWork <http://worldcat.org/entity/work/id/26745098> ;
   schema:inLanguage "en" ;
   schema:name "Bad medicine : the prescription drug industry in the Third World"@en ;
   schema:productID "24376708" ;
   schema:publication <http://www.worldcat.org/title/-/oclc/24376708#PublicationEvent/stanford_calif_stanford_university_press_1992> ;
   schema:publisher <http://experiment.worldcat.org/entity/work/data/26745098#Agent/stanford_university_press> ; # Stanford University Press
   schema:url <http://catdir.loc.gov/catdir/toc/cam027/91005085.html> ;
   schema:url <http://www.gbv.de/dms/bs/toc/025054546.pdf> ;
   schema:workExample <http://worldcat.org/isbn/9780804716697> ;
   wdrs:describedby <http://www.worldcat.org/title/-/oclc/24376708> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/26745098#Agent/stanford_university_press> # Stanford University Press
    a bgn:Agent ;
   schema:name "Stanford University Press" ;
    .

<http://experiment.worldcat.org/entity/work/data/26745098#Organization/drug_industry_standards> # Drug Industry standards
    a schema:Organization ;
   schema:name "Drug Industry standards" ;
    .

<http://experiment.worldcat.org/entity/work/data/26745098#Place/entwicklungslander> # Entwicklungsländer.
    a schema:Place ;
   schema:name "Entwicklungsländer." ;
    .

<http://experiment.worldcat.org/entity/work/data/26745098#Place/stanford_calif> # Stanford, Calif.
    a schema:Place ;
   schema:name "Stanford, Calif." ;
    .

<http://experiment.worldcat.org/entity/work/data/26745098#Topic/arzneimittelversorgung> # Arzneimittelversorgung
    a schema:Intangible ;
   schema:name "Arzneimittelversorgung"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/26745098#Topic/developing_countries> # Developing Countries
    a schema:Intangible ;
   schema:name "Developing Countries"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/26745098#Topic/gesundheitspolitik> # Gesundheitspolitik
    a schema:Intangible ;
   schema:name "Gesundheitspolitik"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/26745098#Topic/pharmaceutical_industry_corrupt_practices_developing_countries> # Pharmaceutical industry--Corrupt practices--Developing countries
    a schema:Intangible ;
   schema:hasPart <http://id.loc.gov/authorities/subjects/sh85039713> ;
   schema:name "Pharmaceutical industry--Corrupt practices--Developing countries"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/26745098#Topic/pharmaceutical_policy_developing_countries> # Pharmaceutical policy--Developing countries
    a schema:Intangible ;
   schema:hasPart <http://id.loc.gov/authorities/subjects/sh85100588> ;
   schema:name "Pharmaceutical policy--Developing countries"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/26745098#Topic/pharmazeutische_industrie> # Pharmazeutische Industrie
    a schema:Intangible ;
   schema:name "Pharmazeutische Industrie"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/26745098#Topic/social_responsibility> # Social Responsibility
    a schema:Intangible ;
   schema:name "Social Responsibility"@en ;
    .

<http://id.worldcat.org/fast/1060133> # Pharmaceutical industry--Corrupt practices
    a schema:Intangible ;
   schema:name "Pharmaceutical industry--Corrupt practices"@en ;
    .

<http://id.worldcat.org/fast/1060194> # Pharmaceutical policy
    a schema:Intangible ;
   schema:name "Pharmaceutical policy"@en ;
    .

<http://id.worldcat.org/fast/1242969> # Developing countries.
    a schema:Place ;
   schema:name "Developing countries." ;
    .

<http://viaf.org/viaf/263277518> # Mia Lydecker
    a schema:Person ;
   schema:birthDate "1926" ;
   schema:familyName "Lydecker" ;
   schema:givenName "Mia" ;
   schema:name "Mia Lydecker" ;
    .

<http://viaf.org/viaf/33296294> # Philip Randolph Lee
    a schema:Person ;
   schema:birthDate "1924" ;
   schema:familyName "Lee" ;
   schema:givenName "Philip Randolph" ;
   schema:givenName "Philip R." ;
   schema:name "Philip Randolph Lee" ;
    .

<http://viaf.org/viaf/45574724> # Milton Silverman
    a schema:Person ;
   schema:birthDate "1910" ;
   schema:familyName "Silverman" ;
   schema:givenName "Milton" ;
   schema:name "Milton Silverman" ;
    .

<http://worldcat.org/isbn/9780804716697>
    a schema:ProductModel ;
   schema:isbn "0804716692" ;
   schema:isbn "9780804716697" ;
    .


Content-negotiable representations

Fermer la fenêtre

Veuillez vous identifier dans WorldCat 

Vous n’avez pas de compte? Vous pouvez facilement créer un compte gratuit.